Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustavo Turecki

Showing results (461-470 of 603) with videos related to

Pageof 61
Sort By:
Molecular Psychiatry|October 13, 2020
Cocaine-related DNA methylation in caudate neurons alters 3D chromatin structure of the IRXA gene clusterKathryn Vaillancourt, Jennie Yang, Gary G Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2018
Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibilityMitra Heshmati, Hossein Aleyasin, Caroline Menard, et al.
Neurochemistry International|July 28, 2012
SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's DiseaseTatiane Katsue Furuya, Patrícia Natália Oliveira da Silva, Spencer Luiz Marques Payão, et al.
Translational Psychiatry|August 22, 2021
Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant responseLaura M Fiori, Massimiliano Orri, Zahia Aouabed, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 21, 2023
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 reportRaegan Mazurka, Simone Cunningham, Stefanie Hassel, et al.
Stem Cell Reports|February 12, 2022
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cellsNuwan C Hettige, Huashan Peng, Hanrong Wu, et al.
BMC Psychiatry|June 4, 2020
A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocolJennifer L Phillips, Natalia Jaworska, Elizabeth Kamler, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 20, 2020
Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxineVictoria S Marshe, Farhana Islam, Malgorzata Maciukiewicz, et al.
Molecular Psychiatry|September 23, 2018
Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samplesKarolina A Aberg, Brian Dean, Andrey A Shabalin, et al.
Pageof 61

Showing results (461-470 of 603) with videos related to

Sort By:
Pageof 61
Molecular Psychiatry|October 13, 2020
Cocaine-related DNA methylation in caudate neurons alters 3D chromatin structure of the IRXA gene clusterKathryn Vaillancourt, Jennie Yang, Gary G Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2018
Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibilityMitra Heshmati, Hossein Aleyasin, Caroline Menard, et al.
Neurochemistry International|July 28, 2012
SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's DiseaseTatiane Katsue Furuya, Patrícia Natália Oliveira da Silva, Spencer Luiz Marques Payão, et al.
Translational Psychiatry|August 22, 2021
Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant responseLaura M Fiori, Massimiliano Orri, Zahia Aouabed, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 21, 2023
Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 reportRaegan Mazurka, Simone Cunningham, Stefanie Hassel, et al.
Stem Cell Reports|February 12, 2022
FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cellsNuwan C Hettige, Huashan Peng, Hanrong Wu, et al.
BMC Psychiatry|June 4, 2020
A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocolJennifer L Phillips, Natalia Jaworska, Elizabeth Kamler, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 20, 2020
Validation study of microRNAs previously associated with antidepressant response in older adults treated for late-life depression with venlafaxineVictoria S Marshe, Farhana Islam, Malgorzata Maciukiewicz, et al.
Molecular Psychiatry|September 23, 2018
Methylome-wide association findings for major depressive disorder overlap in blood and brain and replicate in independent brain samplesKarolina A Aberg, Brian Dean, Andrey A Shabalin, et al.
Pageof 61